Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2024-12-19 |
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="179689"/>
<meta>
<versionId value="5"/>
<lastUpdated value="2024-11-22T11:53:26.327Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<url value="https://fevir.net/resources/EvidenceVariable/179689"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="urn:ietf:rfc:3986"/>
<value value="https://fevir.net/FOI/179689"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.44.24.13"/>
</identifier>
<version value="2.0.0-ballot"/>
<name
value="GroupAssignment_high_dose_xanomeline_vs_low_dose_xanomeline_vs_placebo"/>
<title
value="GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo"/>
<status value="active"/>
<date value="2024-12-19T14:29:51+00:00"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="This example of a GroupAssignment Profile describes a 3-arm trial (so handling='polychotomous') and lists the 3 trial arms in category.name elements. Because the definition of this EvidenceVariable Resource is fully expressed in the handling and category elements, the definition.concept element uses a CodeableConcept for 'Defined in handling and category elements'."/>
<useContext>
<code>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="evidence-communication"/>
<display value="Evidence Communication"/>
</code>
<valueCodeableConcept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="GroupAssignment"/>
<display value="GroupAssignment"/>
</coding>
</valueCodeableConcept>
</useContext>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<relatedArtifact>
<type value="cite-as"/>
<citation
value="GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-12-04. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689."/>
</relatedArtifact>
<handling value="polychotomous"/>
<category>
<name value="high dose xanomeline"/>
</category>
<category>
<name value="low dose xanomeline"/>
</category>
<category>
<name value="placebo"/>
</category>
</EvidenceVariable>